The histone acetylation-related gene signature predicts prognosis and immunotherapy response in stomach adenocarcinoma
Open Access
- 2 September 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1527253
Abstract
Background: Gastric cancer (GC) is a very aggressive, with extreme heterogeneity and rapid growth, most frequently manifested histologically as stomach adenocarcinoma (STAD). Current evidence suggests that histone acetylation is critical for the origin and development of tumors. However, the significance of histone acetylation-related gene signatures for prognosis of STAD patients and mechanisms of histone acetylation in STAD therapy remains unclear.Methods: We identified histone acetylation-related genes in STAD from TCGA and constructed eight-gene signatures by utilizing a univariate Cox regression model with the Least Absolute Shrinkage and Selection Operator (LASSO). In addition, a nomogram was plotted to predict the prognostic significance of the established risk model. We examined associations between our gene signature and somatic mutation, immune subtype, clinicopathological features, tumor microenvironment, immune cell infiltration and immune activity, immunotherapy prediction and drug sensitivity. Cell-based assays were performed to determine the relationship between Doublecortin Like Kinase 1 (DCLK1) and the proliferation, migration and oxaliplatin resistance of GC cells in vitro. Immunohistochemical experiments were used to explore the relationship between DCLK1 and clinicopathological parameters.Results: A prognostic model composed of eight histone acetylation-related genes in STAD was developed. Based on median risk score, the STAD patients were equally assigned into two groups of high- and low-risk, where high-risk represented a less favorable prognosis than low-risk. The two groups showed significant differences with respect to somatic mutation, immune subtype, clinicopathological features, tumor microenvironment, immune cell infiltration and immune activity, immunotherapy prediction and drug sensitivity. The results generated during Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses suggested that Differentially Expressed Genes (DEGs) in the two groups were involved in cancer-related processes and pathways. Cell-based assays indicated that DCLK1 is a promoting factor in gastric cancer and can promote oxaliplatin resistance in gastric cancer cells. Increased DCLK1 expression was also associated with Borrmann’s Type, depth of invasion, lymph node metastasis, and TNM stage in GC patients.Conclusion: A novel histone acetylation-related gene signature, which possesses potential value in predicting the prognosis and immunotherapy effectiveness regarding STAD patients, was developed. This signature may serve as a reliable biomarker for prognosis of STAD and promote the identification of novel treatment targets for STAD. Furthermore, DCLK1 exhibited oncogenic roles and may be a new target for STAD therapy.Keywords
This publication has 81 references indexed in Scilit:
- Cell-Type Enrichment Analysis of Bulk Transcriptomes Using xCell2020
- Immune microenvironment composition in non‐small cell lung cancer and its association with survivalClinical & Translational Immunology, 2020
- Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinomaThe Journal of Pathology, 2019
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- Stomach cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 studyCancer, 2017
- Second-line chemotherapy for patients with advanced gastric cancerGastric Cancer, 2017
- BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric CancerJournal of Cellular Biochemistry, 2016
- Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteinsMolecular Carcinogenesis, 2016
- Expression and localization of axin 2 in colorectal carcinoma and its clinical implicationInternational Journal of Colorectal Disease, 2013
- An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors11Edited by J. ThorntonJournal of Molecular Biology, 2001